Cognitive Impairment Associated with Cancer: A Brief Review.

Published on Feb 1, 2018in Innovations in clinical neuroscience
J. Cara Pendergrass6
Estimated H-index: 6
Steven D. Targum26
Estimated H-index: 26
John Harrison44
Estimated H-index: 44
This brief review explores the areas of cognitive impairment that have been observed in cancer patients and survivors, the cognitive assessment tools used, and the management of the observed cognitive changes. Cognitive changes and impairment observed in patients with cancer and those in remission can be related to the direct effects of cancer itself, nonspecific factors or comorbid conditions that are independent of the actual disease, and/or the treatments or combination of treatments administered. Attention, memory, and executive functioning are the most frequently identified cognitive domains impacted by cancer. However, the prevalence and extent of impairment remains largely unknown due to marked differences in methodology, definitions of cognitive impairment, and the assessment measures used. Assessment of cognitive functioning is an important and necessary part of a comprehensive oncological care plan. Research is needed to establish a better understanding of cognitive changes and impairments associated with cancer so that optimal patient outcomes can be achieved.
ūüďĖ Papers frequently viewed together
#1Dorothy Krolak (Ottawa Hospital Research Institute)H-Index: 1
#2Barbara Collins (Ottawa Hospital Research Institute)H-Index: 16
Last. Richard van der Jagt (Ottawa Hospital Research Institute)H-Index: 17
view all 5 authors...
Purpose The purpose of this study was to estimate the prevalence of cognitive disturbance in lymphoma survivors and to explore relationships between cognitive function and other psychosocial factors.
#1Stephen A. Sands (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 22
#2Brian T. Harel (Yale University)H-Index: 13
Last. Peter D. Cole (Albert Einstein College of Medicine)H-Index: 22
view all 9 authors...
Purpose Neurocognitive impairment is frequently observed among acute lymphoblastic leukemia (ALL) survivors within the domains of intelligence, attention, processing speed, working memory, learning, and memory. However, few have investigated treatment-induced changes in neurocognitive function during the first months of treatment. Additionally, dysfunction during treatment may be preceded by changes in biomarkers measured within cerebrospinal fluid (CSF). Identification of acute declines in neur...
#1Karen Ritchie (University of Montpellier)H-Index: 57
#2Michael T. Ropacki (Janssen Pharmaceutica)H-Index: 8
Last. Craig W. Ritchie (Edin.: University of Edinburgh)H-Index: 47
view all 8 authors...
Abstract The Horizon 2020/IMI European Prevention of Alzheimer's Dementia (EPAD) project will undertake large-scale proof-of-concept trials in predementia Alzheimer's disease (AD). Within EPAD, the monitoring of cognitive trajectories in the preclinical period will constitute a central outcome measure; however, there are currently no clear guidelines as to how this should be achieved as most measures have been developed for the period around dementia diagnosis. The EPAD Scientific Advisory Group...
#1Sunita K. Patel (City of Hope National Medical Center)H-Index: 20
#2Adrienne M. Meier (City of Hope National Medical Center)H-Index: 5
Last. Nicole Delgado (City of Hope National Medical Center)H-Index: 2
view all 6 authors...
Abstract Objective: Computerized tests have increasingly garnered interest for assessing cognitive functioning due to their potential logistical and financial advantages over traditional ‚Äėpencil and-paper‚Äô neuropsychological tests. However, psychometric information is necessary to guide decisions about their clinical and research utility with varied populations. We explored the convergent construct validity and criterion validity of the CogState computerized tests in breast cancer survivors, a g...
#1John HarrisonH-Index: 44
#2Raymond W. Lam (UBC: University of British Columbia)H-Index: 84
Last. Roger S. McIntyre (Toronto Western Hospital)H-Index: 4
view all 4 authors...
#1John Harrison (VUmc: VU University Medical Center)H-Index: 44
#2S√łren Lophaven (Lundbeck)H-Index: 6
Last. Christina Kurre Olsen (Lundbeck)H-Index: 16
view all 3 authors...
Background: These post-hoc analyses evaluated vortioxetine efficacy on cognitive dysfunction in depression. Data were from a double-blind, randomized, fixed-dose, placebo-controlled, 8-week depression study in adults aged 18-65 years (n=602) with DSM-IV-defined major depressive disorder (MDD). Subjects were randomized (1:1:1) to vortioxetine 10mg/day, 20mg/day or placebo. Methods: Cognitive function was assessed at baseline, Week 1 (10mg/day only) and Week 8 using DSST number of correct symbols,...
#1John HarrisonH-Index: 44
#2Roger S. McIntyreH-Index: 99
Last. Danielle S. ChaH-Index: 26
view all 1 authors...
#1Julia Lawrence (Wake Forest University)H-Index: 13
#2Leah Griffin (Wake Forest University)H-Index: 17
Last. Stephen R. Rapp (Wake Forest University)H-Index: 61
view all 10 authors...
Purpose Some breast cancer survivors report cognitive difficulties greater than 1 year after chemotherapy. Acetylcholinesterase inhibitors (AChEI) may improve cognitive impairment. We conducted a randomized, placebo-controlled, pilot study to assess the feasibility of using the AChEI, donepezil, to improve subjective and objective measures of cognitive function in breast cancer survivors.
#1Denise D. Correa (Cornell University)H-Index: 25
#2Maria Kryza-Lacombe (Cornell University)H-Index: 12
Last. Lisa M. DeAngelis (Cornell University)H-Index: 111
view all 5 authors...
Cognitive dysfunction is prevalent among brain tumor patients treated with radiotherapy (RT) and chemotherapy. However, there are no approved pharmacological interventions for cognitive dysfunction in cancer patients. The goal of this pilot study was to examine the efficacy of donepezil, an acetylcholinesterase inhibitor used to treat Alzheimer’s disease, in improving cognitive functions in brain tumor patients previously treated with RT + chemotherapy or chemotherapy alone. Fifteen patients wit...
#1Stephen R. RappH-Index: 61
#2L. Doug CaseH-Index: 11
Last. Edward G. ShawH-Index: 60
view all 13 authors...
Purpose Neurotoxic effects of brain irradiation include cognitive impairment in 50% to 90% of patients. Prior studies have suggested that donepezil, a neurotransmitter modulator, may improve cognitive function. Patients and Methods A total of 198 adult brain tumor survivors ‚Č• 6 months after partial- or whole-brain irradiation were randomly assigned to receive a single daily dose (5 mg for 6 weeks, 10 mg for 18 weeks) of donepezil or placebo. A cognitive test battery assessing memory, attention, ...
Cited By64
#1Josipa Petric (Flinders Medical Centre)H-Index: 1
#2Bahara Sadri (Flinders University)
Last. Nicola R. Dean (Flinders Medical Centre)H-Index: 12
view all 4 authors...
BACKGROUND To investigate the value of audio-recordings in aiding patient understanding and recall of preoperative breast reconstruction information. METHODS This was a prospective cohort study. Participants were randomly allocated into either a recording group who were offered the opportunity to record their breast reconstruction explanation of surgery, or a standard information package group who received standard care. The value of having an audio-recording was assessed by semi-structured inte...
#1Ana Dias-Carvalho (University of Porto)
#2Mariana Sim√Ķes Larraz Ferreira (University of Porto)H-Index: 15
Last. Vera Marisa Costa (University of Porto)H-Index: 27
view all 8 authors...
Cognitive dysfunction has been one of the most reported and studied adverse effects of cancer treatment, but, for many years, it was overlooked by the medical community. Nevertheless, the medical and scientific communities have now recognized that the cognitive deficits caused by chemotherapy have a strong impact on the morbidity of cancer treated patients. In fact, chemotherapy-induced cognitive dysfunction or 'chemobrain' (also named also chemofog) is at present a well-recognized effect of che...
Objective. To investigate the changes in cognitive function and its influencing factors in patients with breast cancer after chemotherapy, to provide a scientific basis for further cognitive correction therapy. Methods. In this study, general information on age, marital status, and chemotherapy regimen was collected from 172 breast cancer chemotherapy patients. 172 patients with breast cancer undergoing chemotherapy were investigated by convenience sampling method, and the subjects were tested o...
#1Hanne Huygelier (Katholieke Universiteit Leuven)H-Index: 6
#2Céline R. Gillebert (Katholieke Universiteit Leuven)H-Index: 20
Last. Pieter Moors (Katholieke Universiteit Leuven)H-Index: 14
view all 3 authors...
OBJECTIVE Clinical neuropsychology has been slow in adopting novelties in psychometrics, statistics, and technology. Researchers have indicated that the stationary nature of clinical neuropsychology endangers its evidence-based character. In addition to a technological crisis, there may be a statistical crisis affecting clinical neuropsychology. That is, the frequentist null hypothesis significance testing framework remains the dominant approach in clinical practice, despite a recent surge in cr...
#1Sithara Vivek (UMN: University of Minnesota)H-Index: 5
#2Heather H. Nelson (UMN: University of Minnesota)H-Index: 69
Last. Bharat Thyagarajan (UMN: University of Minnesota)H-Index: 30
view all 6 authors...
PURPOSE The higher prevalence of cognitive impairment/ dementia among cancer survivors is likely multifactorial. Since both exposures to cytomegalovirus (CMV) and inflammation are common among elderly cancer survivors, we evaluated their contribution towards dementia. METHODS Data from 1387 cancer survivors and 7004 participants without cancer in the 2016 wave of the Health and Retirement Study (HRS) was used in this study. Two inflammatory biomarkers, C-reactive protein (CRP) and neutrophil-lym...
#1Tyler B. Mason (SC: University of Southern California)H-Index: 19
#2Kathryn E. Smith (SC: University of Southern California)H-Index: 18
Purpose Binge eating is defined as consumption of a large amount of food accompanied by a sense of loss of control over eating. While binge eating is associated with poor physical, behavioral, and psychosocial health, it has not been studied in cancer research. Therefore, the overarching goal of this review is to delineate the role of binge eating in cancer research and to spur new research in this area. Specifically, in this review, we outlined (1) binge eating as a possible risk factor that co...
#1Saritha Krishna (UCSF: University of California, San Francisco)H-Index: 8
#2Sofia Kakaizada (UCSF: University of California, San Francisco)H-Index: 5
Last. Shawn L. Hervey-Jumper (UCSF: University of California, San Francisco)H-Index: 23
view all 5 authors...
Gliomas exist within the framework of complex neuronal circuitry in which network dynamics influence both tumor biology and cognition. The generalized impairment of cognition or loss of language function is a common occurrence for glioma patients. The interface between intrinsic brain tumors such as gliomas and functional cognitive networks are poorly understood. The ability to communicate effectively is critically important for receiving oncological therapies and maintaining a high quality of l...
#1Kun Wang (UA: University of Alabama)
#2Leah P. Cheatham (UA: University of Alabama)H-Index: 6
Last. Xiayu Chen (NYU: New York University)
view all 4 authors...
Abstract null null Objectives null This study aimed to examine 1) whether cancer history accelerates older adults’ rates of cognitive decline over time and 2) whether chemotherapy increases older cancer patients’/ survivors’ rates of cognitive decline over time. null null null Methods null This longitudinal study drew a subsample of 8,811 adults aged 65 or older from Wave 6 of the Health and Retirement Study in 2002 and followed biannually until Wave 13 in 2016. Linear mixed-effects models were ...
#1Sarah Braun (VCU: Virginia Commonwealth University)H-Index: 7
#2Farah Aslanzadeh (VCU: Virginia Commonwealth University)H-Index: 2
Last. Ashlee R. Loughan (VCU: Virginia Commonwealth University)H-Index: 5
view all 6 authors...
CogMed Working Memory Training (CWMT) is a computer-based program shown to improve working memory (WM) among those with cognitive impairments. No study to date has investigated its feasibility, acceptability, and satisfaction in adult patients with glioma, despite the well-documented incidence of WM impairment in this population. Twenty patients with glioma and objective and/or perceived WM deficits enrolled in the study: 52% high-grade, 60% female, Mage‚ÄČ=‚ÄČ47 (range‚ÄČ=‚ÄČ21‚Äď72¬†years). Adverse event...
#1Elizabeth A. Salerno (WashU: Washington University in St. Louis)H-Index: 7
#2Eva Culakova (URMC: University of Rochester Medical Center)H-Index: 30
Last. Karen M. Mustian (URMC: University of Rochester Medical Center)H-Index: 58
view all 11 authors...
PURPOSEPhysical activity (PA) is a promising intervention for cancer-related cognitive decline, yet research assessing its use during chemotherapy is limited. This study evaluated patterns of PA be...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.